[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.17224006 [View]
File: 116 KB, 1280x720, 1553245596295.jpg [View same] [iqdb] [saucenao] [google]
17224006

Based TMDX green in a sea of red. God bless those MAssholes.

>> No.17147165 [View]
File: 116 KB, 1280x720, maxresdefault (1).jpg [View same] [iqdb] [saucenao] [google]
17147165

>>17146912
I'm not sure, I don't work or interact with anybody from the company, I just use or see a ton of their products use and track their development. My guess would be that they simply want cash on hand now due to recession fears. Alternatively, I did see that Fidelity picked up another 1.2M shares just yesterday so it could be them cashing out so they can increase their stake.

I'm not really sure what their short term future is. Again, only their last quarter earnings have really been great but I really think they are a good long term hold. In just a year, I have personally seen the transplant industry go from using their products as a part of research studies to now incorporating them as a critical part of their transplant programs. NCDU (Duke) is going nuts with the OCS machine since they had their first successful DCD heart transplant in December. I have also heard that WAUW (University of Washington) is developing their own protocols to the OCS.

Keep in mind that I'm a medfag not a financial analyst, so my views the prospects of the company are speculative and mostly based on the rapid adoption of their FDA approved machines. Don't park your kid's college money in a stock shilled on a Panamanian shuttlecock review forum, but I think that until they can routinely 3D print organs in 50-something years, that the value of this company will only increase.

Navigation
View posts[+24][+48][+96]